Twitter
Linkedin
CRISPR-Cas9
Intellectual Property
Licensing
Knowledge Centre
News
Our Team
Contact Us
Menu
CRISPR-Cas9
Intellectual Property
Licensing
Knowledge Centre
News
Our Team
Contact Us
The global CRISPR/Cas9
licensing leader
Based on the Nobel Prize winning invention of
Emmanuelle Charpentier & Jennifer Doudna,
CRISPR/Cas9 has transformed gene editing.
ERS licenses worldwide access to the essential
CRISPR/Cas9 patent portfolio
Contact us to discuss a license
"This is transformative technology that allows the recoding of life and editing"
Emmanuelle Charpentier
ERS co-founder, patent co-owner
& 2020 Nobel prize winner
The essential intellectual property for the practice of CRISPR/Cas9
Consisting of over 85 issued patents in over 80 countries, our portfolio represents the most foundational collection of CRISPR/Cas9 patents worldwide.
Learn More